Assembly Biosciences, Inc. Share-based Payment Arrangement, Expense
Assembly Biosciences, Inc. (ASMB) reported Share-based Payment Arrangement, Expense of $2.42 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-13
- Assembly Biosciences, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $2.42M, a 189.69% increase year-over-year.
- Assembly Biosciences, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $1.12M, a 56.74% increase year-over-year.
- Assembly Biosciences, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $1.46M, a 94.54% increase year-over-year.
- Assembly Biosciences, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $1.67M, a 109.54% increase year-over-year.
- Assembly Biosciences, Inc. share-based payment arrangement, expense for fiscal 2025 was $4.68M, a 49.90% increase from fiscal 2024.
- Assembly Biosciences, Inc. share-based payment arrangement, expense for fiscal 2024 was $3.12M, a 39.05% decline from fiscal 2023.
- Assembly Biosciences, Inc. share-based payment arrangement, expense for fiscal 2023 was $5.12M, a 22.36% decline from fiscal 2022.
- Assembly Biosciences, Inc. share-based payment arrangement, expense for fiscal 2022 was $6.59M, a 25.89% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 0 month | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.42M 10-Q · filed 2026-08-13 | $3.53M 10-Q · filed 2026-08-13 | $4.99M derived: sum of 3 quarters · filed 2026-08-13 | $6.66M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2026-03-31 | $1.12M 10-Q · filed 2026-05-07 | $2.58M derived: sum of 2 quarters · filed 2026-05-07 | $4.25M derived: sum of 3 quarters · filed 2026-05-07 | $5.08M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $3.13M derived: sum of 2 quarters · filed 2026-03-19 | $3.96M derived: sum of 3 quarters · filed 2026-08-13 | $4.68M 10-K · filed 2026-03-19 | |||||
| 2025-09-30 | $1.67M 10-Q · filed 2025-11-10 | $2.50M derived: sum of 2 quarters · filed 2026-08-13 | $3.22M 10-Q · filed 2025-11-10 | $3.97M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-06-30 | $834.00K 10-Q · filed 2026-08-13 | $1.55M 10-Q · filed 2026-08-13 | $2.30M derived: sum of 3 quarters · filed 2026-08-13 | $3.09M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-03-31 | $712.00K 10-Q · filed 2026-05-07 | $1.46M derived: sum of 2 quarters · filed 2026-05-07 | $2.26M derived: sum of 3 quarters · filed 2026-05-07 | $3.09M derived: sum of 4 quarters · filed 2026-05-07 | |||||
| 2024-12-31 | $751.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $1.55M derived: sum of 2 quarters · filed 2026-03-19 | $2.38M derived: sum of 3 quarters · filed 2026-03-19 | $3.12M 10-K · filed 2026-03-19 | |||||
| 2024-09-30 | $797.00K 10-Q · filed 2025-11-10 | $1.63M derived: sum of 2 quarters · filed 2025-11-10 | $2.37M 10-Q · filed 2025-11-10 | $3.33M derived: sum of 4 quarters · filed 2025-11-10 | |||||
| 2024-06-30 | $833.00K 10-Q · filed 2025-08-06 | $1.57M 10-Q · filed 2025-08-06 | $2.53M derived: sum of 3 quarters · filed 2025-08-06 | $3.67M derived: sum of 4 quarters · filed 2025-08-06 | |||||
| 2024-03-31 | $739.00K 10-Q · filed 2025-05-08 | $1.70M derived: sum of 2 quarters · filed 2025-05-08 | $2.83M derived: sum of 3 quarters · filed 2025-05-08 | $4.02M derived: sum of 4 quarters · filed 2025-05-08 | |||||
| 2023-12-31 | $959.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $2.09M derived: sum of 2 quarters · filed 2025-03-20 | $3.28M derived: sum of 3 quarters · filed 2025-03-20 | $5.12M 10-K · filed 2025-03-20 | |||||
| 2023-09-30 | $1.14M 10-Q · filed 2024-11-07 | $2.33M derived: sum of 2 quarters · filed 2024-11-07 | $4.16M 10-Q · filed 2024-11-07 | $6.17M derived: sum of 4 quarters · filed 2024-11-07 | |||||
| 2023-06-30 | $1.19M 10-Q · filed 2024-08-08 | $3.02M 10-Q · filed 2024-08-08 | $5.04M derived: sum of 3 quarters · filed 2024-08-08 | $6.59M derived: sum of 4 quarters · filed 2024-08-08 | |||||
| 2023-03-31 | $1.83M 10-Q · filed 2024-05-08 | $3.85M derived: sum of 2 quarters · filed 2024-05-08 | $5.40M derived: sum of 3 quarters · filed 2024-05-08 | $6.99M derived: sum of 4 quarters · filed 2024-05-08 | |||||
| 2022-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $3.57M derived: sum of 2 quarters · filed 2024-03-28 | $5.15M derived: sum of 3 quarters · filed 2024-03-28 | $6.59M 10-K · filed 2024-03-28 | |||||
| 2022-09-30 | $1.56M 10-Q · filed 2023-11-08 | $3.14M derived: sum of 2 quarters · filed 2023-11-08 | $4.58M 10-Q · filed 2023-11-08 | $6.53M derived: sum of 4 quarters · filed 2023-11-08 | |||||
| 2022-06-30 | $1.58M 10-Q · filed 2023-08-09 | $3.02M 10-Q · filed 2023-08-09 | $4.97M derived: sum of 3 quarters · filed 2023-08-09 | $6.56M derived: sum of 4 quarters · filed 2023-08-09 | |||||
| 2022-03-31 | $1.44M 10-Q · filed 2023-05-04 | $3.39M derived: sum of 2 quarters · filed 2023-05-04 | $4.98M derived: sum of 3 quarters · filed 2023-05-04 | $6.97M derived: sum of 4 quarters · filed 2023-05-04 | |||||
| 2021-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $3.54M derived: sum of 2 quarters · filed 2023-03-22 | $5.52M derived: sum of 3 quarters · filed 2023-03-22 | $5.24M 10-K · filed 2023-03-22 | |||||
| 2021-09-30 | $1.59M 10-Q · filed 2022-11-08 | $3.58M derived: sum of 2 quarters · filed 2022-11-08 | $3.29M 10-Q · filed 2022-11-08 | $7.04M derived: sum of 4 quarters · filed 2022-11-08 | |||||
| 2021-06-30 | $1.99M 10-Q · filed 2022-08-09 | $1.70M 10-Q · filed 2022-08-09 | $5.45M derived: sum of 3 quarters · filed 2022-08-09 | $11.49M derived: sum of 4 quarters · filed 2022-08-09 | |||||
| 2021-03-31 | -$286.00K 10-Q · filed 2022-05-12 | $3.46M derived: sum of 2 quarters · filed 2022-05-12 | $9.51M derived: sum of 3 quarters · filed 2022-05-12 | $16.64M derived: sum of 4 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | $3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $9.79M derived: sum of 2 quarters · filed 2022-03-11 | $16.93M derived: sum of 3 quarters · filed 2022-03-11 | $21.85M 10-K · filed 2022-03-11 | |||||
| 2020-09-30 | $6.05M 10-Q · filed 2021-11-04 | $13.18M derived: sum of 2 quarters · filed 2021-11-04 | $18.11M 10-Q · filed 2021-11-04 | $24.61M derived: sum of 4 quarters · filed 2021-11-04 | |||||
| 2020-06-30 | $7.13M 10-Q · filed 2021-08-05 | $12.06M 10-Q · filed 2021-08-05 | $18.57M derived: sum of 3 quarters · filed 2021-08-05 | $23.97M derived: sum of 4 quarters · filed 2021-08-05 | |||||
| 2020-03-31 | $4.92M 10-Q · filed 2021-05-06 | $11.43M derived: sum of 2 quarters · filed 2021-05-06 | $16.84M derived: sum of 3 quarters · filed 2021-05-06 | $18.91M derived: sum of 4 quarters · filed 2021-05-06 | |||||
| 2019-12-31 | $6.51M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $11.91M derived: sum of 2 quarters · filed 2021-02-25 | $13.98M derived: sum of 3 quarters · filed 2021-02-25 | $20.56M 10-K · filed 2021-02-25 | |||||
| 2019-09-30 | $5.40M 10-Q · filed 2020-11-05 | $7.47M derived: sum of 2 quarters · filed 2020-11-05 | $14.05M 10-Q · filed 2020-11-05 | $20.86M derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2019-06-30 | $2.07M 10-Q · filed 2020-08-05 | $8.64M 10-Q · filed 2020-08-05 | $15.45M derived: sum of 3 quarters · filed 2021-02-25 | $21.46M derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2019-03-31 | $6.58M 10-Q · filed 2020-05-08 | $13.38M derived: sum of 2 quarters · filed 2021-02-25 | $19.39M derived: sum of 3 quarters · filed 2021-02-25 | $30.98M derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2018-12-31 | $6.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $12.81M derived: sum of 2 quarters · filed 2021-02-25 | $24.40M derived: sum of 3 quarters · filed 2021-02-25 | $28.48M 10-K · filed 2021-02-25 | |||||
| 2018-09-30 | $6.01M 10-Q · filed 2019-11-07 | $6.01M 10-Q · filed 2018-11-08 | $17.59M derived: sum of 2 quarters · filed 2019-11-07 | $21.68M 10-Q · filed 2019-11-07 | $21.68M 10-Q · filed 2018-11-08 | $24.45M derived: sum of 4 quarters · filed 2020-03-04 | |||
| 2018-06-30 | $11.59M 10-Q · filed 2019-08-05 | $11.59M 10-Q · filed 2018-08-08 | $15.67M 10-Q · filed 2019-08-05 | $15.67M 10-Q · filed 2018-08-08 | $18.44M derived: sum of 3 quarters · filed 2020-03-04 | $21.04M derived: sum of 4 quarters · filed 2020-03-04 | |||
| 2018-03-31 | $4.08M 10-Q · filed 2019-05-09 | $4.08M 10-Q · filed 2018-05-07 | $6.85M derived: sum of 2 quarters · filed 2020-03-04 | $9.45M derived: sum of 3 quarters · filed 2020-03-04 | $11.46M derived: sum of 4 quarters · filed 2020-03-04 | ||||
| 2017-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $5.37M derived: sum of 2 quarters · filed 2020-03-04 | $7.38M derived: sum of 3 quarters · filed 2020-03-04 | $8.60M 10-K · filed 2020-03-04 | $8.60M 10-K · filed 2018-03-08 | ||||
| 2017-09-30 | $2.60M 10-Q · filed 2018-11-08 | $4.61M derived: sum of 2 quarters · filed 2018-11-08 | $5.83M 10-Q · filed 2018-11-08 | $6.82M derived: sum of 4 quarters · filed 2019-02-28 | |||||
| 2017-06-30 | $2.01M 10-Q · filed 2018-08-08 | $3.24M 10-Q · filed 2018-08-08 | $4.23M derived: sum of 3 quarters · filed 2019-02-28 | $5.28M derived: sum of 4 quarters · filed 2019-02-28 | |||||
| 2017-03-31 | $1.22M 10-Q · filed 2018-05-07 | $2.22M derived: sum of 2 quarters · filed 2019-02-28 | $3.27M derived: sum of 3 quarters · filed 2019-02-28 | $4.79M derived: sum of 4 quarters · filed 2019-02-28 | |||||
| 2016-12-31 | $990.96K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $2.05M derived: sum of 2 quarters · filed 2019-02-28 | $3.56M derived: sum of 3 quarters · filed 2019-02-28 | $5.02M 10-K · filed 2019-02-28 | $5.02M 10-K · filed 2017-03-02 | ||||
| 2016-09-30 | $1.06M 10-Q · filed 2017-11-01 | $2.57M derived: sum of 2 quarters · filed 2017-11-01 | $4.03M 10-Q · filed 2017-11-01 | $5.55M derived: sum of 4 quarters · filed 2018-03-08 | |||||
| 2016-06-30 | $1.52M 10-Q · filed 2017-08-09 | $2.98M 10-Q · filed 2017-08-09 | $4.50M derived: sum of 3 quarters · filed 2018-03-08 | $5.65M derived: sum of 4 quarters · filed 2018-03-08 | |||||
| 2016-03-31 | $1.46M 10-Q · filed 2017-05-08 | $2.98M derived: sum of 2 quarters · filed 2018-03-08 | $4.13M derived: sum of 3 quarters · filed 2018-03-08 | $6.75M derived: sum of 4 quarters · filed 2018-03-08 | |||||
| 2015-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $2.67M derived: sum of 2 quarters · filed 2018-03-08 | $5.29M derived: sum of 3 quarters · filed 2018-03-08 | $7.88M 10-K · filed 2018-03-08 | |||||
| 2015-09-30 | $1.15M 10-Q · filed 2016-11-09 | $3.77M derived: sum of 2 quarters · filed 2016-11-09 | $6.36M 10-Q · filed 2016-11-09 | $8.99M derived: sum of 4 quarters · filed 2017-03-02 | |||||
| 2015-06-30 | $2.62M 10-Q · filed 2016-08-09 | $5.21M 10-Q · filed 2016-08-09 | $7.84M derived: sum of 3 quarters · filed 2017-03-02 | $15.28M derived: sum of 4 quarters · filed 2017-03-02 | |||||
| 2015-03-31 | $2.59M 10-Q · filed 2016-05-10 | $5.22M derived: sum of 2 quarters · filed 2017-03-02 | $12.66M derived: sum of 3 quarters · filed 2017-03-02 | $12.97M derived: sum of 4 quarters · filed 2017-03-02 | |||||
| 2014-12-31 | $2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $10.07M derived: sum of 2 quarters · filed 2017-03-02 | $10.38M derived: sum of 3 quarters · filed 2017-03-02 | $10.64M 10-K · filed 2017-03-02 | |||||
| 2014-09-30 | $7.43M 10-Q · filed 2015-11-09 | $7.75M derived: sum of 2 quarters · filed 2015-11-09 | $8.00M 10-Q · filed 2015-11-09 | ||||||
| 2014-07-10 | $15.00M 10-K · filed 2015-03-16 | ||||||||
| 2014-06-30 | $312.80K 10-Q · filed 2015-08-13 | $567.51K 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |